Introduction: The nursing profession is characterized as one of the most stressful and emotional dementing professions. It is widely agreed that many nurses are experiencing anxiety and depression as a results of their profession. Purpose: The purpose of this study was to assess the prevalence and associated factors of depression and anxiety among mental health nurses working in public psychiatric hospitals, in order to identify independent predictors of mental health disorders risk. Material and Methods: A descriptive, cross-sectional study was conducted in which 110 mental health nurses who were working in public psychiatric hospitals of Greece participated. The Patient Health Questionnaire-2 (PHQ-2) and the Generalized Anxiety Disorder-2 (GAD-2) questionnaire along with a sheet with basics demographic, social, and work characteristics, including gender, age, marital status, educational level, working experience in nursing, working position and shift, were used as instrument for data collection. Results:The mean age of the nurses was 42.64 years (SD = 5.87 years) and working experience in nursing 15.73 years (SD = 5.64 years). Most participants were women 64.5%, married 59.1% and nursing assistant 53.6%, while 48.2% of them held a higher education degree.A very large percentage found to be classified as depressed (52.7%) and anxious (48.2%) and factors that found to be associated were age, marital status and educational level (for depression and anxiety) and working experience (only for depression). Conclusions: Mental health nurses are in high risk for developing psychiatric disorders such as depression and anxiety. Being single, divorced or widowed, older, with many years of experience and a higher education degree can be predicting factors associated with depression and anxiety in mental health nurses.
This study gives an overview of the views and beliefs of nurses about the problems and barriers involved in PU prevention and treatment. The study reveals that although some barriers to good practice may exist, nurses can hold a positive attitude toward PU prevention and treatment, and their perceived value of prevention and treatment may help nurses to overcome the barriers in managing PUs.
Purpose:Post-operative pain after breast cancer surgery is a major problem and women undergoing mastectomy and breast reconstruction experience post-operative pain syndromes in approximately one-half of all cases. Patients who have undergone breast reconstruction after mastectomy can suffer from acute postoperative pain with moderate or strong tension. In some cases, chronic neuropathic pain syndromes may occur after surgery. Opioids are used to treat pain, with serious side effects. The systemic postoperative analgesic regimen as thiocochlicoside P.O. along with paracetamol and NSAIDs I.V., which may limit the administration of opioids without reducing pain relief, seems to be necessary.Materials and Methods:This study was a clinical trial randomizing 70 patients undergoing breast reconstruction. Two main protocols of systematic post-operative analgesia, one using thiocochlicoside (group A) and the other without them (group B), were used. Both groups received paracetamol X3 and lornoxicam X2 I.V. systematically. The pain measurement scale (NPS) used to measure post-operative pain. Likert scales were used to evaluate patient’s satisfaction and the difficulty from the side effects . An anonymous questionnaire was used for the data collection.Results:Statistically significant difference was found between pain on the day of surgery (p = 0.017) as well as the three subsequent days (p = 0.000). In group A , pain was reduced directly to half (Χ2 surgery pain = 93.888, p = 0.000) especially on the first post-operative day. In group A the satisfaction with analgesic treatment was higher than in group B (p = 0.002).Conclusion:The use of thiocochlicoside in post-operative analgesia in breast reconstruction after mastectomy contributes to reduce the pain intensity experienced by patients and to reduce the side effects of opioid analgesics as a result of reduced demand for opioid analgesics. Patients who received the analgesia using muscle relaxants-spasmolytic reported greater satisfaction.
Introduction: Chronic Renal Failure (CRF) is a chronic disease, which has a negative impact on the quality of patients’ life. The study of factors affecting the quality of life of these patients is necessary to investigate the impact of the disease in a biological, psychological and social level.Aim: The purpose of this research study was to investigate the satisfaction of patients undergoing chronic hemodialysis and their perceptions of their quality of life.Material and Method: The study sample consisted of patients undergoing chronic hemodialysis at a Dialysis Unit in Athens. The study lasted from January 2016 to March 2016. To measure the health related quality of patients’ life, the Greek version of the questionnaire WHOQOL-BREF of the World Health Organization was used. The completion of the questionnaires was made by the method of the structured interview. A total of 70 questionnaires were completed.Results: According to the study results, most of the patients considered the quality of their life as good (48.6%), while the 8.5% described it as bad or very bad. The lowest satisfaction rates associated with issues of physical health and independence with mean (12.89 ± 2.23) and the highest with social relations (14.68 ± 1.50).Conclusion: The effect of Chronic Renal Failure on the physical, psychological and social background of patients on dialysis is an essential factor in creating a tailor-made holistic treatment program, adjusted to the specific needs of each patient.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.